Inactive Instrument

Company Zomedica Corp. Toronto S.E.

Equities

ZOM

CA98980M1095

Healthcare Facilities & Services

Business Summary

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Number of employees: 144

Sales per Business

USD in Million2022Weight2023Weight Delta
Therapeutics
94.5 %
19 97.9 % 24 94.5 % +28.43%
Diagnostics
5.5 %
0 2.1 % 1 5.5 % +252.17%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
19 100.0 % 25 100.0 % +33.05%

Managers

Managers TitleAgeSince
Chief Executive Officer 67 30/09/21
Director of Finance/CFO 54 15/03/23
Chief Tech/Sci/R&D Officer - 31/12/17
Chief Tech/Sci/R&D Officer - 31/12/18
Chief Operating Officer 63 31/12/21
Director/Board Member 66 15/06/20
General Counsel 56 30/05/22
Human Resources Officer - 01/01/22
Sales & Marketing - -
Corporate Officer/Principal - 16/05/21

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 67 30/09/21
Director/Board Member 62 15/08/19
Director/Board Member 66 15/06/20
Director/Board Member 53 12/09/21
Chairman 68 26/04/16
Director/Board Member 63 26/04/16
Director/Board Member 61 22/08/22
Director/Board Member 54 08/07/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 979,949,668 963,832,238 ( 98.36 %) 0 98.36 %

Shareholders

NameEquities%Valuation
Vanguard Global Advisers LLC
4.932 %
48,326,991 4.932 % 8 M $
12,240,480 1.249 % 2 M $
Geode Capital Management LLC
1.033 %
10,120,991 1.033 % 2 M $
BlackRock Institutional Trust Co. NA
1.006 %
9,862,981 1.006 % 2 M $
3,110,581 0.3174 % 519 467 $
Brown Brothers Harriman & Co. (Investment Management)
0.2517 %
2,466,532 0.2517 % 411 911 $
2,225,000 0.2271 % 371 575 $
2,000,050 0.2041 % 334 008 $
Northern Trust Investments, Inc.(Investment Management)
0.1835 %
1,798,385 0.1835 % 300 330 $
Atom Investors LP
0.1226 %
1,201,048 0.1226 % 200 575 $

Company contact information

Zomedica Corp.

100 Phoenix Drive Suite 125

48108-2635, Ann Arbor

+

http://www.zomedica.com
address Zomedica Corp.(ZOM)